The best international medical expertise

Alan Barkun is director of the Therapeutic Endoscopy Third Tier Fellowship Training Program in the Division of Gastroenterology at McGill University and the McGill University Health Centre, Montréal, Canada. He is recipient of the DG Kinnear Chair in Gastroenterology at McGill University, holding a medical degree and an MSc in epidemiology and biostatistics from McGill University. Recipient of many national and international awards, Dr. Barkun has published over 700 peer-reviewed articles and abstracts, and has given over 600 international presentations on emerging digestive endoscopic technologies, with an emphasis on methodological, clinical and cost-effectiveness trials of treatments for upper gastrointestinal bleeding (UGIB), biliopancreatic diseases and colorectal cancer screening. He is also the current Chair of the colorectal Cancer screening implementation committee for the province of Quebec. Most recently he was awarded the Visiting Clinician Scientist Award in 2019 and the 2020 Distinguished Service Award by the Canadian Association of Gastroenterology.

Chantal Séguin, MD is an Associate Professor in the Department of Medicine, Division of Hematology and Oncology at The McGill University Health Center, and a Clinician Investigator in the Bone Engineering and Vascular Biology Research Lab at the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, QC. She has completed a fellowship in endothelial cell biology at the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, under the supervision of William C. Aird, M.D. Since her return to McGill University, she has been involved in teaching hematology with an emphasis on blood coagulation and thrombosis. Her main focus of research involves the study of the endothelial and vascular complications following cancer therapy as well as active clinical research on venous thrombosis, including thrombosis in the cancer population. Also, Chantal has developed an endothelial cell-based approach to osteonecrosis of the femoral head, a vascular complication seen frequently in patients affected with acute lymphoblastic leukemia as a result of high dose glucocorticoids. She also identified a novel gain-of-function mutation in TRPV4 in patients affected with inherited osteonecrosis of the femoral head.

Dr. Nathaniel Bouganim is an Assistant Professor in the Department of Oncology at the McGill University Health Center (MUHC) in Montreal, Quebec. He also serves currently as the director of the oncology clinical teaching unit, as well as the fellowship program director for medical Oncology. Dr. Bouganim is a very active researcher with multiple investigator-led clinical trials, and is principal investigator on numerous clinical trials in both breast and head and neck cancers. He is the recipient of numerous awards for his research.

Dr. David Mulder is a graduate of the University of Saskatchewan and completed his training in General Surgery at the Montreal General Hospital. He followed this with a specialized training in Chest Surgery at the University of Iowa and also has a Master’s of Science from McGill University. Dr. David Mulder is a former Surgeon-in-chief of the Montreal General Hospital (MGH), Chairman of the Department of Surgery and Director of the Division of Cardiovascular and Thoracic Surgery at McGill University. Currently he is the senior staff surgeon at the McGill University Health Centre (MUHC) Department of Surgery, Division of Thoracic Surgery and current Chief Surgeon of the Montreal Canadiens organization and has been honored by the MUHC community with the naming of the Dr. David S. Mulder Trauma Centre at the Montreal General Hospital.
A leader in traumatology and cardio-thoracic surgery, he is one of the reasons the Montreal General Hospital is ranked among the top trauma centres in Quebec. With Dr. Léon Dontigny of Université de Montréal, Dr. Mulder actively participated in the American College of Surgeons Committee on Trauma, reporting on the study materials for future Canadian surgeons and providing vital doctrines on efficient treatment of trauma. The second Canadian to preside over the American Association for the Surgery of Trauma, Dr. Mulder has contributed to the international influence of the Trauma Association of Canada.
Dr. Mulder has been a leader as a surgeon, a scholar and educator for over 50 years. He has also been involved with the McGill Sports Medicine Centre since 1994 and served as President of the NHL Team Physicians Society from 2003 to 2006 and is currently the Head Team physician for the Montreal Canadians hockey club. He became a Member of the Order of Canada in 1997, has received the Award of Merit from the Montreal General Hospital and has been awarded the USA National Safety Council Award for his role in developing a province wide trauma system in Quebec.

Colin Chalk graduated from McGill University (MD,CM 1984), trained in neurology at Mayo Clinic and Oxford University, and completed a fellowship in peripheral nerve diseases at Mayo Clinic. He returned to McGill in 1991, and is now Professor in the Department of Neurology and Neurosurgery. From 2004 to 2019 he was the Director of the Division of Neurology, Montréal General Hospital. He runs peripheral neuropathy and myasthenia gravis clinics at the Montréal General Hospital, and is in charge of the Montréal General’s EMG laboratory. He also has a major administrative and teaching role in the McGill Faculty of Medicine’s undergraduate medical curriculum. His scholarly work in neuromuscular disease includes several Cochrane reviews, participation in multicentre clinical trials, and papers on clinical aspects of neuromuscular disease.

Dr. Giovanni Artho has been an Assistant Professor of Radiology at McGill University since 2002. His particular expertise is Abdominal Radiology along with the training and education of Radiology residents at McGill and has been the head of the Selection Committee since 2005.